Gambro is a Swedish-based medical technology company that develops, manufactures and supplies products and therapies for kidney and liver dialysis, myeloma kidney therapy and other extracorporeal therapies for chronic and acute patients.
The deal may be finalized within two weeks. Baxter has been negotiating with Gambro for almost a year.
Baxter International is headquartered in Deerfield, Ill.
Related Articles on Company Acquisitions:
Alcon Acquires Ophthalmic Division of Sensomotoric Instruments
Wright Medical to Acquire BioMimetic Therapeutics
Allergan to Acquire SkinMedica
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.